With the rapid development of biotechnology, tumor research has ushered in unprecedented opportunities. In this process, animal models play a crucial role as a bridge between basic research and clinical applications. The CDX model platform of InnoModels Biotechnology, with its unique advantages, opens up a new path for tumor research.
1. Highly simulates the human tumor environment
CDX model, i.e. patient-derived xenograft model, is a model that simulates the growth and metastasis of human tumors by implanting tumor cells from patients into experimental animals. By accurately simulating the human tumor environment, InnoModels' CDX model platform provides researchers with a research platform that is extremely close to the real thing. This enables researchers to observe and study the growth, invasion and metastasis of tumor cells in conditions closer to the actual human body, providing more accurate and effective strategies for tumor treatment.
2. Abundant Tumor Cell Resources
InnoModels Biotechnology has more than 500 validated tumor cell lines, which provide researchers with a wide range of choices. Whether it is subcutaneous inoculation, in situ inoculation or systemic inoculation, the CDX model platform can provide flexible and versatile experimental solutions to meet the various needs of researchers for tumor models. In addition, the platform can be used in combination with PBMC humanized immune system reconstructed mice and CD34+HSC humanized immune system humanized mice, which further enhances the realism and practicality of the model.

3、Powerful drug efficacy evaluation capability
An important application of the CDX modeling platform is for drug development and evaluation. By conducting in vivo efficacy experiments on this platform, researchers can visualize the inhibitory effects of drugs on tumor cells and evaluate the efficacy and safety of drugs. The CDX modeling platform of InnoModels Biotechnology has a high success rate and stability, which can ensure the reliability and reproducibility of experimental results. This provides strong support for drug development and helps accelerate the process of new drug development, providing better treatment options for patients.
4、Promote multidisciplinary cooperation and communication
CDX modeling platform is not only applicable to oncology research, but also widely used in immunology, pharmacology, toxicology and other disciplines. This platform provides a platform for researchers from different disciplines to communicate and cooperate, and promotes interdisciplinary research cooperation. Through multidisciplinary cooperation and communication, the mechanisms of tumor occurrence, development and metastasis can be deeply explored, providing new ideas and methods for comprehensive treatment of tumors.
5、Exploration of personalized treatment plan
The CDX model platform also has the potential to explore personalized treatment plans. By implanting patients' tumor cells into experimental animals, researchers can observe the response of tumor cells to different treatment plans, and thus develop personalized treatment plans for patients. This personalized treatment plan can maximize the therapeutic effect, reduce unnecessary side effects, and bring better quality of life to patients.
In conclusion, the CDX model platform of InnoModels Biotechnology has become an important tool in the field of tumor research due to its high simulation of the human tumor environment, rich tumor cell resources, powerful drug efficacy assessment capability, promotion of multidisciplinary cooperation and communication, and potential for exploration of personalized treatment plans. The platform provides researchers with a reliable, practical and efficient research platform for basic tumor research, clinical research and drug development. With the continuous progress and innovation of technology, the CDX model platform will play an even more important role in tumor research and make greater contributions to human health.